Search

Dr. Blinderman is a national leader in supportive care.

… Wednesday, November 1, 2023 Craig D. Blinderman, MD has been appointed Chief of the Supportive Care Service at Memorial Sloan Kettering Cancer Center (MSK). Dr. Blinderman is a national leader in supportive care who comes to MSK from Columbia University Medical Center/NewYork-Presbyterian Hospital, where

Learn how MSK uses TIL therapy for melanoma — the first cell therapy approved by the FDA to treat a solid tumor.

… Monday, February 19, 2024 By the summer of 2022, Roberto Romero was running out of options to treat the melanoma he’d been coping with since 2015. He’d already had several surgeries and many rounds of drug treatment. But the cancer — which started as a dark spot under a toenail — continued to grow and

Learn whether eating soy products causes cancer.

… Wednesday, July 27, 2022 “Does eating soy cause breast cancer?” It’s a question regularly posed to Julia Brockway-Marchello , a Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist at MSK Nassau in Uniondale, New York. But her answer is a clear and decisive no. “Soy is actually helpful

Surprise! It has to do with metabolism.

… Wednesday, September 18, 2019 Summary The most commonly mutated gene in cancer,  p53, works by shifting cell metabolism in a way that alters a cell’s identity, researchers at the Sloan Kettering Institute have discovered. More than 50% of all cancers contain a mutation in the p53 gene. The protein made

New MSK research marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health; uncovers how changes to “helper” proteins drive cancer cell survival; develops a new model for investigating lung cancer metastasis; and uses AI to improve outcome predictions in sarcoma.

… Wednesday, November 6, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health

Meghan Winston chose Memorial Sloan Kettering Cancer Center to surgically remove her stomach—called a total gastrectomy—to protect against a deadly form of stomach cancer caused by a rare mutation in the CDH1 gene.

… Wednesday, July 13, 2022 Meghan and Ryan Meghan Winston (right) with her fiancée Ryan Ferri. Meghan’s stomach was surgically removed at Memorial Sloan Kettering Cancer Center, to prevent the high risk she would develop a deadly stomach cancer due to a rare genetic mutation called CDH1. “I was scared

According to a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan- Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) project identified genetic mutations and pathways that distinctly set the disease apart not only from other types of ovarian cancer, but from other solid tumors as well.

… Wednesday, June 29, 2011 According to a large-scale genomic analysis of the most common and aggressive type of ovarian cancer , researchers from Memorial Sloan Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) project identified genetic mutations and pathways that distinctly

Find answers about rectal bleeding, including hemorrhoids and cancer, from an MSK specialist.

… Wednesday, March 4, 2026 If you notice blood in your stool or when you wipe, it’s natural to feel worried — and maybe a little embarrassed to tell anyone, even your doctor. But it’s important to recognize when something isn’t right and to know when you should speak to a healthcare provider.  “Talking

Paige Arnold, a graduate student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), is one of 13 PhD candidates selected from around the world to receive a Harold M. Weintraub Graduate Student Award for the quality, originality, and significance of their doctoral research.

… Wednesday, March 2, 2022 Paige Arnold , a graduate student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), is one of 13 PhD candidates selected from around the world to receive a Harold M. Weintraub Graduate Student Award for the quality, originality, and significance of

A new drug could be an effective treatment for some people with low-grade glioma.

… Wednesday, August 7, 2024 Brain tumors are among the deadliest and most difficult cancers to treat. But the US Food and Drug Administration (FDA) has now approved a new drug that slows the growth of low-grade diffuse gliomas with a certain gene mutation.  “This represents the first new treatment option